Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Henry

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
AIDS Research and Human Retroviruses|May 14, 2016
Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011Pragna Patel, Timothy Bush, E Milu Kojic, et al.
AIDS Research and Human Retroviruses|April 13, 2011
Cystatin C and baseline renal function among HIV-infected persons in the SUN StudyEdgar Turner Overton, Pragna Patel, Kristin Mondy, et al.
The Journal of Biological Chemistry|November 8, 2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressantsL Keith Henry, Julie R Field, Erika M Adkins, et al.
The Lancet. HIV|October 2, 2015
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b studyJean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.
AIDS Patient Care and Stds|May 24, 2007
Demographic, clinical, and virologic characteristics of African-born persons with HIV/AIDS in a Minnesota hospitalOmobosola O Akinsete, Tracy Sides, Diane Hirigoyen, et al.
Journal of the International AIDS Society|November 14, 2014
Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGOJean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.
Nature Communications|January 26, 2016
Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membraneBen D Richardson, Kaustuv Saha, Danielle Krout, et al.
ACS Chemical Neuroscience|January 23, 2019
Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional ConsequencesMeagan A Quinlan, Danielle Krout, Rania M Katamish, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
AIDS (London, England)|August 28, 2007
Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg, Jacqueline Neuhaus, Mark Bower, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
AIDS Research and Human Retroviruses|May 14, 2016
Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011Pragna Patel, Timothy Bush, E Milu Kojic, et al.
AIDS Research and Human Retroviruses|April 13, 2011
Cystatin C and baseline renal function among HIV-infected persons in the SUN StudyEdgar Turner Overton, Pragna Patel, Kristin Mondy, et al.
The Journal of Biological Chemistry|November 8, 2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressantsL Keith Henry, Julie R Field, Erika M Adkins, et al.
The Lancet. HIV|October 2, 2015
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b studyJean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.
AIDS Patient Care and Stds|May 24, 2007
Demographic, clinical, and virologic characteristics of African-born persons with HIV/AIDS in a Minnesota hospitalOmobosola O Akinsete, Tracy Sides, Diane Hirigoyen, et al.
Journal of the International AIDS Society|November 14, 2014
Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGOJean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.
Nature Communications|January 26, 2016
Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membraneBen D Richardson, Kaustuv Saha, Danielle Krout, et al.
ACS Chemical Neuroscience|January 23, 2019
Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional ConsequencesMeagan A Quinlan, Danielle Krout, Rania M Katamish, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
AIDS (London, England)|August 28, 2007
Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg, Jacqueline Neuhaus, Mark Bower, et al.
Pageof 14